newsfilter
← Latest News
GlobeNewswire·

Rapport Therapeutics Reports Third Quarter Financials and Provides Business Update

Biotech industry leaders added to the Board of Directors, bringing deep expertise in drug discovery, neuroscience clinical development, and operational leadershipRAP-219 MAD-2 and PET trials ongoing; topline data